Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

NCT03066466 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants were enrolled

Conditions

Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: Atorvastatin
DRUG: Methotrexate
DRUG: Tacrolimus

Sponsor

Loyola University